.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prospective clinical investigation of modulated electro hyperthermia as an adjunct to neoadjuvant chemotherapy in breast cancer patients: Enhancing efficacy and objective assessment

Termin

Datum: 27.09.2023

Zeit: 17:30 – 17:30

Redezeit: 0 Min.

Diskussionszeit: 0 Min.

Ort / Stream:

Poster 2

Session

Clinical applications & Trial

Thema

Hyperthermia Drug Delivery, Nanoparticles

Mitwirkende

Dr. A. Marcell Szasz (Budapest, HU), P. Arkosy (Debrecen, HU), A. Bassam (Gyula, HU), N. Bittner (Budapest, HU), Gy Bodoky (Budapest, HU), K. Boer (Budapest, HU), D Mathe (Budapest, HU), B Gyorffy (Budapest, HU), Z Herold (Budapest, HU), M Herold (Budapest, HU), E Lengyel (Budapest, HU), M Luzbetak (Duesseldorf, DE), Gy Marko-Varga (Lund, SE), Zs Nagy (Budapest, HU), S Spisak (Budapest, HU), Z Szallasi (Boston, MA, US), Gy Szentmartoni (Budapest, HU), M Dank (Budapest, HU)